SeqLL staff members may be attending conferences that we are not exhibiting in. If you would like to check if a staff member will be at a conference, please just send an email to info@seqll.com
Dr. Robison from Omics! Omics! spent the morning with us, here is what he had to say I’ve written in the past about SeqLL, the company which purchased all of the hard assets from [...]
Wednesday, November 3, 2017 WOBURN, MA ‐‐ SeqLL, LLC announced today that it has installed a true Single Molecule Sequencing (tSMS) Instrument at the Harvard‐MGH Cancer Center to support [...]
Tuesday, July 11, 2017 WOBURN, MA — SeqLL, LLC announced today that it has been awarded a Phase I SBIR grant in the amount of $223,465 by the NIH/National Human Genome Research Institute to [...]
We have recently added a Case Study Section to our website so you can see how tSMS technology is being utilized by leading researchers for multiple cutting edge applications. Here is our first [...]
Application Highlight Epigenetics is the study of environmental stresses creating changes in gene expression that can be passed to offspring. These changes leave the underlying DNA sequence [...]
SeqLL Expands Early Access Program for New true Single Molecule Sequencing (tSMS™) Benchtop System Quantitative sequencing platform addresses limitations of other sequencing technologies. WOBURN, [...]
SeqLL Launches Early Access Program for New true Single Molecule Sequencing (tSMS™) Benchtop System Quantitative sequencing platform addresses limitations of other sequencing technologies. [...]
We’d like to welcome you to the new and improved SeqLL.com. Please feel free to look around our site and find out why so many people are talking about True Single Molecule Sequencing. [...]
Technology
Learn how True Single Molecule Sequencing works and how it is different from standard sequencing approaches.
